Hong Kong Science and Technology Parks Corporation

Institution (Nonprofit)

Homepage Wikipedia ROR

Also Known As

Hong Kong Science and Technology Parks Corporation, 香港科技园公司 · Acronym: HKSTP

2.4K

Publications

141K

Citations

107

Authors

838

Concepts

About

Hong Kong Science and Technology Parks Corporation is a nonprofit institution in Shatin, Hong Kong known for medicine, engineering, and covid-19.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	42	319	16.4K
2	Business	11	17	837
3	Health Sciences	10	37	1.3K
4	Education	4	4	138
5	Arts	1	1	23

Hong Kong Science and Technology Parks Corporation

2.4K

Publications

141K

Citations

Page 1

	Year	Citations
SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo Kenrie P. Y. Hui, John Chi Wang Ho, Man Chun Cheung, Nature Human BronchusLung InflammationRespiratory DiseasesImmunologyPathology	2022	870
Antibody evasion properties of SARS-CoV-2 Omicron sublineages Sho Iketani, Lihong Liu, Yicheng Guo, Nature	2022	848
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron Nature Sars-cov-2 B.1.1.529 OmicronPathogenesisViral PathogenesisImmunologyVirology	2022	648
Lithium Batteries and the Solid Electrolyte Interphase (SEI)—Progress and Outlook Henry Adenusi, Gregory A. Chass, Stefano Passerini, Advanced Energy Materials EngineeringMachine LearningChemistryChemical EngineeringGraphite Anode	2023	608
Insight on Organic Molecules in Aqueous Zn‐Ion Batteries with an Emphasis on the Zn Anode Regulation Donghong Wang, Qing Li, Yuwei Zhao, Advanced Energy Materials EngineeringAppropriate Organic MoleculesChemistryAqueous BatteryAqueous Zn‐ion Batteries	2022	450
AAV capsid variants with brain-wide transgene expression and decreased liver targeting after intravenous delivery in mouse and marmoset David Goertsen, Nicholas C. Flytzanis, Nick Goeden, Nature Neuroscience HepatologyLiver PhysiologyImmunologyAav Capsid VariantsPathology	2021	386
Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination Samuel M. S. Cheng, Chris Ka Pun Mok, Yonna W. Y. Leung, Nature Medicine VaccinationHeterologous CoronavacVaccine DevelopmentImmunologyVirology	2022	371
Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study Martina McMenamin, Joshua Nealon, Yun Lin, The Lancet Infectious Diseases VaccinationVaccinologyPopulation-based Observational StudyPreventive MedicineCovid-19 Pandemic	2022	363
AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor Feng Ren, Xiao Ding, Min Zheng, Chemical Science	2023	292
Toxicity and Estrogenic Endocrine Disrupting Activity of Phthalates and Their Mixtures Xueping Chen, Shisan Xu, Tianfeng Tan, International Journal of Environmental Research and Public Health Flexible PlasticsEnvironmental ChemistryAquacultureEnvironmental HealthToxicology	2014	284

Page 1